🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of Tylenol, asserting the firms hid potential risks that the pain reliever presented to pediatric neurological development.

This legal action follows thirty days after Donald Trump publicized an unproven link between using Tylenol - referred to as paracetamol - while pregnant and autism in offspring.

The attorney general is filing suit against Johnson & Johnson, which once produced the medication, the only pain reliever approved for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he said they "betrayed America by profiting off of discomfort and promoting medication without regard for the risks."

The company asserts there is no credible evidence linking Tylenol to autism.

"These companies deceived for years, intentionally threatening numerous people to increase profits," the attorney general, a Republican, stated.

Kenvue commented that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the welfare of US mothers and children."

On its website, Kenvue also stated it had "consistently assessed the relevant science and there is no credible data that indicates a established connection between taking paracetamol and autism spectrum disorder."

Groups speaking for doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in Tylenol - is one of the few options for expectant mothers to address pain and elevated temperature, which can present major wellness concerns if not addressed.

"In over twenty years of studies on the use of paracetamol in pregnancy, no reliable research has conclusively proven that the consumption of acetaminophen in any stage of gestation causes brain development issues in young ones," the association stated.

This legal action cites current declarations from the Trump administration in asserting the drug is reportedly hazardous.

In recent weeks, the former president caused concern from health experts when he instructed expectant mothers to "resist strongly" not to consume Tylenol when sick.

Federal regulators then issued a notice that medical professionals should think about restricting the consumption of Tylenol, while also declaring that "a causal relationship" between the drug and autism spectrum disorder in children has not been proven.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had pledged in spring to initiate "extensive scientific investigation" that would identify the source of autism spectrum disorder in a limited time.

But experts cautioned that finding a sole reason of autism spectrum disorder - believed by scientists to be the result of a complex mix of inherited and external influences - would prove challenging.

Autism is a type of enduring cognitive variation and disability that affects how people experience and engage with the surroundings, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is running for federal office - alleges the manufacturer and J&J "willfully ignored and sought to suppress the research" around acetaminophen and autism spectrum disorder.

The case attempts to require the corporations "eliminate any promotional materials" that claims Tylenol is safe for expectant mothers.

This legal action parallels the grievances of a assembly of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in recently.

The court threw out the legal action, saying studies from the plaintiffs' authorities was not conclusive.